Your browser doesn't support javascript.
loading
Perioperative administration of recombinant activated factor VII in a Glanzmann's thrombasthenia patient with platelet refractoriness: case report
Bisinotto, Flora Margarida Barra; Martins, Laura Bisinotto; Camargos, Giovanini Pires de; Bianco, Marcelo de Paula.
Afiliación
  • Bisinotto, Flora Margarida Barra; CET/SBA Integrado de Uberaba. Uberaba. BR
  • Martins, Laura Bisinotto; CET/SBA Integrado de Uberaba. Uberaba. BR
  • Camargos, Giovanini Pires de; Universidade de Uberaba. Faculdade de Medicina. Uberaba. BR
  • Bianco, Marcelo de Paula; Universidade de Uberaba. Uberaba. BR
Braz. J. Anesth. (Impr.) ; 72(6): 823-825, Nov.-Dec. 2022.
Article en En | LILACS | ID: biblio-1420620
Biblioteca responsable: BR891.2
ABSTRACT
Abstract Glanzmannʼs Trombasthenia (GT) is a genetic disorder, that develops with a tendency toward bleeding and is characterized by the absence or decrease in platelet aggregation. Surgical bleeding may be difficult to control. Platelet transfusion is the main treatment, albeit refractoriness can occur. We describe the case of a patient with GT and platelet refractoriness, who was submitted to radical prostatectomy and dental extraction. The perioperative treatment with apheresis platelet concentrate and activated recombinant factor seven allowed the procedures to be performed uneventfully. We discuss the complexity of the case and the treatment option.
Asunto(s)
Palabras clave

Texto completo: 1 Índice: LILACS Asunto principal: Trombastenia Límite: Humans / Male Idioma: En Revista: Braz. J. Anesth. (Impr.) Año: 2022 Tipo del documento: Article

Texto completo: 1 Índice: LILACS Asunto principal: Trombastenia Límite: Humans / Male Idioma: En Revista: Braz. J. Anesth. (Impr.) Año: 2022 Tipo del documento: Article